珠城科技(301280.SZ):目前已經進入了部分新能源汽車供應鏈的供貨體系
格隆匯2月23日丨珠城科技(301280.SZ)於2024年2月23日接受投資者調研,就“公司汽車連接器目前情況如何?”,公司回覆稱,目前公司已經進入了部分新能源汽車供應鏈的供貨體系,如瑞浦蘭鈞、金康新能源等新能源汽車零部件供應商及零跑汽車、比亞迪等新能源汽車製造商。接下來,公司將着力於突破國內新能源汽車客户(如奇瑞新能源汽車、吉利汽車等)的認證壁壘、產品技術壁壘及管理壁壘,把握後入行業市場的優勢,分析現有行業產品技術數據,針對客户特定的需求,提供更高效可靠的產品和服務。通過制定專業的客户開拓、挖掘、銷售和維護的體系,及時將潛在客户轉化為現有客户。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.